Pneumonectomy for stage i (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival Christos Alexiou, FRCS, David Beggs, FETCS,

Slides:

Advertisements

Similar presentations

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Advertisements

Elizabeth A. David, MD, David T

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002 Antonio L Visbal, MD, Brent.

Thomas J. Birdas, MD, Richard P. M

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,

Primary non-Hodgkin’s lymphoma of the lung

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Chun Chieh Lin, PhD, MBA, Matthew P

Quality of life after tailored combined surgery for stage I non–small-cell lung cancer and severe emphysema Eugenio Pompeo, MD, Enrico De Dominicis,

Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S

Completion pneumonectomy: analysis of operative mortality and survival

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Surgery for coarctation of the aorta in infants weighing less than 2 kg Emile A Bacha, MD, Melvin Almodovar, MD, David L Wessel, MD, David Zurakowski,

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer Akihito Watanabe, MD, Masao Hosokawa, MD,

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Survival after resection of synchronous non–small cell lung cancer

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma Timothy E Sawyer, MD, James A Bonner, MD, Perry M Gould,

Andrea S. Wolf, MD, MPH, Scott J

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Survival of Patients With or Without Symptoms Undergoing Potentially Curative Resections for Primary Lung Cancer Andrea R.G. Sheel, BS (Hons), MBChB,

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Sex-associated differences in survival of patients undergoing resection for lung cancer Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel.

Morbidity and mortality after 94 extrapleural pneumonectomies for empyema Yuji Shiraishi, MD, Yutsuki Nakajima, MD, Akira Koyama, MD, Keiichiro Takasuna,

Resection of Intraabdominal Tumors With Cavoatrial Extension Using Deep Hypothermic Circulatory Arrest Christopher Lau, MD, Padraic O’Malley, MD, Mario.

Lung Cancer Surgery in Patients With Liver Cirrhosis

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Observational Study on the Beneficial Effect of Preoperative Statins in Reducing Atrial Fibrillation After Coronary Surgery Giovanni Mariscalco, MD,

Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non–Small Cell Lung Cancer in the U.S. National Cancer Data Base

Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic.

Prognostic factors in clinical stage I non–small cell lung cancer

Early pulmonary resection for localized mycobacterium avium complex disease Yuji Shiraishi, MD, Kanae Fukushima, MD, Hikotaro Komatsu, MD, Atsuyuki Kurashima,

Expression of Nuclear Factor-κB and Its Clinical Significance in Nonsmall-Cell Lung Cancer Zhenfa Zhang, MD, Jianqun Ma, MD, Ni Li, PhD, Nan Sun, MD,

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Prognostic factors after surgical treatment of lung cancer invading the diaphragm Gaetano Rocco, MD, Erino A Rendina, MD, Alberto Meroni, MD, Federico.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer Thomas W Rice, MD, David J Adelstein, MD, Jay P Ciezki,

Pulmonary Resection for Lung Cancer in Octogenarians

Douglas E. Paull, MD, Glenda M. Updyke, PA-C, Michael A

Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection Emilie Perrot, MD, Benoit Guibert, MD, Pierre Mulsant,

Is there a role for pneumonectomy in pulmonary metastases?1

Improving results of the modified Fontan operation in patients with heterotaxy syndrome Christof Stamm, MD, Ingeborg Friehs, MD, Lennart F Duebener, MD,

Development of a patient-centered aggregate score to predict survival after lung resection for non–small cell lung cancer Alessandro Brunelli, MD, Michele.

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Superior sulcus lung tumors: Impact of local control on survival

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Neal S Goldstein, MD The Annals of Thoracic Surgery

Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Steven M Keller, MD, Sudeshna Adak,

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker Adnan Sayar,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Long-term outcome after coronary artery bypass grafting in patients with severe left ventricular dysfunction John Alfred Carr, MD, Benjamin E Haithcock,

Mark I. Block, MD The Annals of Thoracic Surgery

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms Robert E. Merritt, MD, Douglas J. Mathisen,

Thirty-Day Mortality Underestimates the Risk of Early Death After Major Resections for Thoracic Malignancies Robert R. McMillan, MD, MPH, Alexandra Berger,

Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W

Presentation transcript:

Pneumonectomy for stage i (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival Christos Alexiou, FRCS, David Beggs, FETCS, Patrick Onyeaka, FRCS, Kostas Kotidis, FRCS, Sudip Ghosh, FRCS, Lynda Beggs, RGN, David N Hopkinson, FRCS, John P Duffy, FRCS, W.Ellis Morgan, FRCS, Gaetano Rocco, FETCS The Annals of Thoracic Surgery Volume 76, Issue 4, Pages 1023-1028 (October 2003) DOI: 10.1016/S0003-4975(03)00883-X

Fig 1 Overall Kaplan-Meier survival estimates for patients undergoing a lung resection smaller than pneumonectomy (continuous line) and pneumonectomy (interrupted line) (log rank test, p = 0.0006; Breslow test, p < 0.0001; and Tarone–Ware tests, p < 0.0001). The numbers in parentheses represent the upper and lower 95% confidence interval limits. The Annals of Thoracic Surgery 2003 76, 1023-1028DOI: (10.1016/S0003-4975(03)00883-X)

Fig 2 Kaplan-Meier survival estimates after a lung resection smaller than pneumonectomy (continuous line) and pneumonectomy (interrupted line) for patients having T1N0 disease (log rank, Breslow, and Tarone–Ware tests, p = 0.002). The numbers in parentheses represent the lower and upper 95% confidence interval limits. The Annals of Thoracic Surgery 2003 76, 1023-1028DOI: (10.1016/S0003-4975(03)00883-X)

Fig 3 Kaplan-Meier survival estimates after a lung resection smaller than pneumonectomy (continuous line) and pneumonectomy (interrupted line) for patients having T2N0 disease (log rank test, p = 0.04; Breslow test, p = 0.0001; and Tarone–Ware test, p = 0.001). The numbers in parentheses represent the lower and upper 95% confidence interval limits. The survival curves overlap 5 years postoperatively (when relatively small numbers of patients remain at risk), but there is a marked difference in the estimated median survival between the groups. The Annals of Thoracic Surgery 2003 76, 1023-1028DOI: (10.1016/S0003-4975(03)00883-X)